Log in

OTCMKTS:SSMXYSYSMEX CORP/ADR Stock Price, Forecast & News

$39.60
-0.30 (-0.75 %)
(As of 06/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$39.47
Now: $39.60
$40.40
50-Day Range
$32.80
MA: $35.95
$39.90
52-Week Range
$26.29
Now: $39.60
$40.40
Volume16,371 shs
Average Volume27,656 shs
Market Capitalization$16.53 billion
P/E Ratio46.59
Dividend Yield0.30%
Beta0.11
Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, sale, and export/import of diagnostic instruments, reagents, and related software for the use in hematology, urinalysis, immunochemistry, clinical chemistry, and hemostasis. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; systems for high-volume testing in labs; and hematology analyzers for animals. The company also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for to test for liver fibrosis progression and atopic dermatitis; and support services for hemostasis products. In addition, it offers systems for the detection of cancer lymph node metastasis; cytogenic testing services; and lab assay services. It serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. The company operates in the Americas, Europe, the Middle East, Africa, the Asia Pacific, China, and Japan. Sysmex Corporation has a collaboration with MolecularMD Corporation to develop and commercialize companion diagnostics; and a strategic collaboration with Biolidics Limited for the development of laboratory assays in the field of circulating tumor cells. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.90 out of 5 stars


Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SSMXY
CUSIPN/A
CIKN/A
Phone817-8265-0500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.66 billion
Cash Flow$1.24 per share
Book Value$5.72 per share

Profitability

Net Income$371.02 million

Miscellaneous

Employees8,715
Market Cap$16.53 billion
Next Earnings Date6/3/2020 (Estimated)
OptionableNot Optionable

Receive SSMXY News and Ratings via Email

Sign-up to receive the latest news and ratings for SSMXY and its competitors with MarketBeat's FREE daily newsletter.

SYSMEX CORP/ADR (OTCMKTS:SSMXY) Frequently Asked Questions

How has SYSMEX CORP/ADR's stock been impacted by COVID-19 (Coronavirus)?

SYSMEX CORP/ADR's stock was trading at $30.62 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SSMXY shares have increased by 29.3% and is now trading at $39.60. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of SYSMEX CORP/ADR?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SYSMEX CORP/ADR in the last year. There are currently 1 sell rating and 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for SYSMEX CORP/ADR.

When is SYSMEX CORP/ADR's next earnings date?

SYSMEX CORP/ADR is scheduled to release its next quarterly earnings announcement on Wednesday, June 3rd 2020. View our earnings forecast for SYSMEX CORP/ADR.

Has SYSMEX CORP/ADR been receiving favorable news coverage?

Media coverage about SSMXY stock has been trending very positive this week, InfoTrie reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SYSMEX CORP/ADR earned a media sentiment score of 3.5 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutSYSMEX CORP/ADR.

Who are some of SYSMEX CORP/ADR's key competitors?

Who are SYSMEX CORP/ADR's key executives?

SYSMEX CORP/ADR's management team includes the following people:
  • Mr. Hisashi Ietsugu, Chairman of the Managing Board, CEO & Pres
  • Mr. Yukio Nakajima, Sr. Exec. Officer, Sr. MD, CFO & Member of the Managing Board
  • Mr. Kaoru Asano, CTO, COO LS Bus. Unit, Sr. MD, Sr. Exec. Officer & Member of the Managing Board (Age 74)
  • Mr. Frank Buescher, Exec. Officer
  • Mr. Yukio Hamaguchi, Sr. Exec. Officer

What is SYSMEX CORP/ADR's stock symbol?

SYSMEX CORP/ADR trades on the OTCMKTS under the ticker symbol "SSMXY."

How do I buy shares of SYSMEX CORP/ADR?

Shares of SSMXY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SYSMEX CORP/ADR's stock price today?

One share of SSMXY stock can currently be purchased for approximately $39.60.

How big of a company is SYSMEX CORP/ADR?

SYSMEX CORP/ADR has a market capitalization of $16.53 billion and generates $2.66 billion in revenue each year. The company earns $371.02 million in net income (profit) each year or $0.90 on an earnings per share basis. SYSMEX CORP/ADR employs 8,715 workers across the globe.

What is SYSMEX CORP/ADR's official website?

The official website for SYSMEX CORP/ADR is www.sysmex.co.jp.

How can I contact SYSMEX CORP/ADR?

SYSMEX CORP/ADR's mailing address is 1-5-1 Wakinohama-Kaigandori Chuo-ku, Kobe M0, 651-0073. The company can be reached via phone at 817-8265-0500.

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.